📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2017.1423183

PubMed Identifier: 29721381

Publication URI: http://europepmc.org/abstract/MED/29721381

Type: Journal Article/Review

Volume: 7

Parent Publication: Oncoimmunology

Issue: 5

ISSN: 2162-4011